“Guinea-Bissau Health Minister Denies Approval of Danish-Led Newborn Hepatitis B Vaccine Tr” — what this page in the network covers. Guinea-Bissau’s Minister of Health has publicly stated that the government “did not authorize” a controversial hepatitis B study in newborns, contradicting earlier indications that the Danish-led trial would proceed with funding from the US government and private partners. The study, which focuses on tracking nonspecific health outcomes such as overall mortality and neurodevelopmental conditions rather than vaccine safety or efficacy, has been championed by Robert F. Kennedy Jr., the US Secretary of Health and Human Services and a prominent anti-vaccine activist.
The denial raises questions about the future of the trial and highlights tensions between local health authorities and international research agendas. With global scrutiny on vaccine research ethics and the involvement of high-profile figures like RFK Jr., the situation underscores the challenges of conducting clinical trials in low-income countries. This listing links straight to the original page, where the content is available in full.
